[
  {
    "ts": "2025-10-11T14:05:47+00:00",
    "headline": "Charles River Labs (CRL): Examining Valuation Following Recent Share Price Rebound",
    "summary": "Charles River Laboratories International (CRL) has caught the eye of investors recently as its stock performance over the past month shows an uptick of around 9%. This rise invites a closer look at how the company is being valued now in comparison to recent trends. See our latest analysis for Charles River Laboratories International. So far this year, Charles River Laboratories International’s momentum has been mixed. A 1-month share price return of nearly 9% has helped to offset some...",
    "url": "https://finance.yahoo.com/news/charles-river-labs-crl-examining-140547450.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ad4ef188-39fb-3894-8313-671872c2ad6c",
      "content": {
        "id": "ad4ef188-39fb-3894-8313-671872c2ad6c",
        "contentType": "STORY",
        "title": "Charles River Labs (CRL): Examining Valuation Following Recent Share Price Rebound",
        "description": "",
        "summary": "Charles River Laboratories International (CRL) has caught the eye of investors recently as its stock performance over the past month shows an uptick of around 9%. This rise invites a closer look at how the company is being valued now in comparison to recent trends. See our latest analysis for Charles River Laboratories International. So far this year, Charles River Laboratories International’s momentum has been mixed. A 1-month share price return of nearly 9% has helped to offset some...",
        "pubDate": "2025-10-11T14:05:47Z",
        "displayTime": "2025-10-11T14:05:47Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0Ih9Jyeb4E8RAOq22ZtFHA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r5jgPUxQrxmcesBmGBKgkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-labs-crl-examining-140547450.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-labs-crl-examining-140547450.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]